Skip to main content
. Author manuscript; available in PMC: 2010 Aug 1.
Published in final edited form as: Bioorg Med Chem Lett. 2009 May 13;19(15):4467–4470. doi: 10.1016/j.bmcl.2009.05.029

Figure 3.

Figure 3

Compound 9 (ALW-II-49–7) inhibits EphB2 tyrosine kinase activity. The U87 glioblastoma cells were either left untreated or treated for 1 hr with indicated concentrations of ALW-II-49–7 in the presence of ephrinB1. Total lysates were subject to immunoprecipitation with an anti-EphB2 antibody, and immunoprecipitated EphB2 was analyzed by western blot with an anti-phosphotyrosine antibody (top). The blot was reprobed with an anti-EphB2 antibody to show equal loading of proteins (bottom).